Table 5.

Comparison of Unrelated Donor Umbilical Cord Blood and Unmanipulated Unrelated BM Stem Cell Transplantation in Children

Demographics
Median Age (range) in yrHLA A, B, DR, B1 Match5-150HLA A, B, DR, B1 1-Antigen MismatchHLA A, B, DR, B1 2- or 3-Antigen MismatchGrade II-IV aGVHDGrade III-IV aGVHD
 
Unrelated donor umbilical cord blood transplantation 4.1 (0.1-23.5) 8 (19%) 16 (73%) 19 (24%) 57% 9% 
Unrelated donor unmanipulated BMT 9.1 (0.5-17.8) 46 (54%) 41 (45%) 1 (1%) 90% 49% 
       
Demographics
Median Age (range) in yrHLA A, B, DR, B1 Match5-150HLA A, B, DR, B1 1-Antigen MismatchHLA A, B, DR, B1 2- or 3-Antigen MismatchGrade II-IV aGVHDGrade III-IV aGVHD
 
Unrelated donor umbilical cord blood transplantation 4.1 (0.1-23.5) 8 (19%) 16 (73%) 19 (24%) 57% 9% 
Unrelated donor unmanipulated BMT 9.1 (0.5-17.8) 46 (54%) 41 (45%) 1 (1%) 90% 49% 
       
 Search and Engraftment 
 Median ANC ≥500/μL (days) Median Platelet ≥50,000/μL Median Nuc Cells/kg Infused (range) × 107 
  (days)  
Unrelated donor umbilical cord blood transplantation 23 75 3.7 (0.7-40.0) 
Unrelated donor unmanipulated BMT 21 235-151 42 (12-460) 
    
 Search and Engraftment 
 Median ANC ≥500/μL (days) Median Platelet ≥50,000/μL Median Nuc Cells/kg Infused (range) × 107 
  (days)  
Unrelated donor umbilical cord blood transplantation 23 75 3.7 (0.7-40.0) 
Unrelated donor unmanipulated BMT 21 235-151 42 (12-460) 
    
 HLA Disparity and Incidence of Acute GvHD 
 HLA A, B, DR, B1 Match5-152 Grade II-IV aGVHD (%) Grade III-IV aGVHD (%) HLA A, B, DR, B1 1-Antigen Mismatch Grade II-IV aGVHD (%) Grade III-IV aGVHD (%) 
       
 
Unrelated donor umbilical cord blood transplantation n = 6 33% 16% n = 14 43% 7% 
Unrelated donor unmanipulated BMT n = 46 83% 37% n = 41 98% 62% 
 HLA Disparity and Incidence of Acute GvHD 
 HLA A, B, DR, B1 Match5-152 Grade II-IV aGVHD (%) Grade III-IV aGVHD (%) HLA A, B, DR, B1 1-Antigen Mismatch Grade II-IV aGVHD (%) Grade III-IV aGVHD (%) 
       
 
Unrelated donor umbilical cord blood transplantation n = 6 33% 16% n = 14 43% 7% 
Unrelated donor unmanipulated BMT n = 46 83% 37% n = 41 98% 62% 

Data are from previous studies.64,65 67 

F5-150

HLA A, B, DR by serology. HLA DR B1 by high resolution DNA typing.

F5-151

Forty-four patients excluded from analysis because of earlier discharge, relapse, or death before platelet recovery.

F5-152

Evaluable for aGVHD.

or Create an Account

Close Modal
Close Modal